Copyright 1999 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.1999
We read with great interest the study by van der Klauw et al1 of drug-associated agranulocytosis in a Dutch hospital. We agree with their conclusions (the highest risks of drug-induced agranulocytosis occur with thyroid inhibitors, the combination drug sulfamethoxazole-trimethoprim, sulfasalazine, clomipramine hydrochloride, and dipyrone combined with analgesics) and want to give some data from our own experience.2
Emmanuel A, Maloisel F. Drug-Associated Agranulocytosis: Experience at Strasbourg Teaching Hospital. Arch Intern Med. 1999;159(19):2366–2367. doi:
Customize your JAMA Network experience by selecting one or more topics from the list below.